Frontiers in Pharmacology · 2019 · 11 citations · 52 references
Life SciencesNeurobiologyNeuroscienceCellular NeuroscienceMolecular NeuroscienceNeurochemistryHypoxic-ischemic Brain InjuryHypoxic-ischemic EncephalopathyMicroglia BiologyNeuroinflammationNeuroprotectionStrokeCerebral Hypoxic-ischemic InjuryCerebral Ischemia NeuroprotectionIschemic Stroke PathophysiologyNeuroprotective MechanismsReactive Oxygen Species GenerationReactive Oxygen Species InjuryRodent Cerebral IschemiaStroke Neuroprotection
by downregulating the expressions of caspase-3 and NF-кB mRNA during ischemia and reperfusion and that of p38 and caspase-3 during acute ischemia and reperfusion as well as the steady-state levels of excitatory amino acids/inhibitory amino acids and by improving the total antioxidant capacity and total superoxide dismutase activities during ischemia. These findings provide new molecular evidence for the mechanisms underlying ZXC action.
52
Heart disease and stroke statistics--2015 update: a report from the American Heart Association.
Dariush Mozaffarian, Emelia J. Benjamin, Alan S. Go et al. · PubMed · 2015 · 8.3K citations
Reversible middle cerebral artery occlusion without craniectomy in rats.
Enrique Zea Longa, Philip R. Weinstein, Shaun W. Carlson et al. · Stroke · 1989 · 7.5K citations · Full text
Medicine, Neuroscience, Surgery +17
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
Werner Hacke, Markku Kaste, Erich Bluhmki et al. · New England Journal of Medicine · 2008 · 6.6K citations · Full text
Heart Disease and Stroke Statistics—2015 Update
Dariush Mozaffarian, Emelia J. Benjamin, Alan S. Go et al. · Circulation · 2014 · 5.8K citations